Chemoinformaics analysis of 2-Methoxy-2,9-dimethylbenzonorbornene
| Molecular Weight | 202.297 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 13 |
| Exact Molecular Weight | 202.136 | nRing | 3 |
| Solubility: LogS | -4.581 | nHRing | 0 |
| Solubility: LogP | 3.689 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 36.1843 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.679 |
| Synth | 4.518 |
| Natural Product Likeliness | 1.181 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.107 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.461 |
| MDCK | 0.0000247 |
| BBB | 0.546 |
| PPB | 0.940195 |
| VDSS | 2.105 |
| FU | 0.0421951 |
| CYP1A2-inh | 0.296 |
| CYP1A2-sub | 0.878 |
| CYP2c19-inh | 0.325 |
| CYP2c19-sub | 0.955 |
| CYP2c9-inh | 0.254 |
| CYP2c9-sub | 0.574 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.873 |
| CYP3a4-inh | 0.292 |
| CYP3a4-sub | 0.751 |
| CL | 11.208 |
| T12 | 0.088 |
| hERG | 0.033 |
| Ames | 0.547 |
| ROA | 0.652 |
| SkinSen | 0.067 |
| Carcinogencity | 0.41 |
| EI | 0.047 |
| Respiratory | 0.79 |
| NR-Aromatase | 0.091 |
| Antiviral | Yes |
| Prediction | 0.657604 |